Cytokine gene variations associated with trait and state anxiety in oncology patients and their family caregivers

Supportive Care in Cancer

Volumn 23, Issue 4, 2015, Pages 953-965

  Miaskowski, Christine ^a   Cataldo, Janine K ^a   Baggott, Christina R ^a   West, Claudia ^a   Dunn, Laura B ^b   Dhruva, Anand ^b   Merriman, John D ^c   Langford, Dale J ^a   Kober, Kord M ^a   Paul, Steven M ^a   Cooper, Bruce A ^a   Aouizerat, Bradley E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Anxiety; Cancer; Cytokines; Family caregiver; Radiation therapy; Single nucleotide polymorphism; State anxiety; Trait anxiety

Indexed keywords

CYTOKINE; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR TYPE II; NUCLEAR FACTOR KAPPA BETA 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ANXIETY; ARTICLE; BRAIN CANCER; BREAST CANCER; CANCER PATIENT; CANCER RADIOTHERAPY; CAREGIVER; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; FAMILY; FEMALE; HUMAN; INFLAMMATION; KARNOFSKY PERFORMANCE STATUS; LONGITUDINAL STUDY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; PROSTATE CANCER; QUESTIONNAIRE; SINGLE NUCLEOTIDE POLYMORPHISM; STATE ANXIETY; STATE TRAIT ANXIETY INVENTORY; SYMPTOM; TRAIT ANXIETY; AGE DISTRIBUTION; AGED; GENETIC VARIATION; GENETICS; GENOTYPE; MIDDLE AGED; NEOPLASMS; PHENOTYPE; PSYCHOLOGY; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; SEX RATIO; STATISTICS AND NUMERICAL DATA;

AGE DISTRIBUTION; AGED; ANXIETY; CAREGIVERS; CYTOKINES; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PHENOTYPE; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION;

EID: 84942098239     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-014-2443-5     Document Type: Article

References (97)

1. Cliff A, MacDonagh R (2000) Psychosocial morbidity in prostate cancer: II. A comparison of patients and partners. BJU Int 86:834–839
2. Clavarino AM, Lowe JB, Carmont SA, Balanda K (2002) The needs of cancer patients and their families from rural and remote areas of Queensland. Aust J Rural Health 10:188–195
3. Linden W, Vodermaier A, Mackenzie R, Greig D (2012) Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord 141:343–351. doi:10.1016/j.jad.2012.03.025
4. Janda M, Steginga S, Dunn J, Langbecker D, Walker D, Eakin E (2008) Unmet supportive care needs and interest in services among patients with a brain tumour and their carers. Patient Educ Couns 71:251–258
5. Brintzenhofe-Szoc KM, Levin TT, Li Y, Kissane DW, Zabora JR (2009) Mixed anxiety/depression symptoms in a large cancer cohort: prevalence by cancer type. Psychosomatics 50:383–391
6. Bruera E, Schmitz B, Pither J, Neumann CM, Hanson J (2000) The frequency and correlates of dyspnea in patients with advanced cancer. J Pain Symptom Manag 19:357–362
7. Tchekmedyian NS, Kallich J, McDermott A, Fayers P, Erder MH (2003) The relationship between psychologic distress and cancer-related fatigue. Cancer 98:198–203. doi:10.1002/cncr.11463
8. Andrykowski MA (1990) The role of anxiety in the development of anticipatory nausea in cancer chemotherapy: a review and synthesis. Psychosom Med 52:458–475
9. Delgado-Guay M, Parsons HA, Li Z, Palmer JL, Bruera E (2009) Symptom distress in advanced cancer patients with anxiety and depression in the palliative care setting. Support Care Cancer 17:573–579. doi:10.1007/s00520-008-0529-7
10. Smith EM, Gomm SA, Dickens CM (2003) Assessing the independent contribution to quality of life from anxiety and depression in patients with advanced cancer. Palliat Med 17:509–513
11. Spencer R, Nilsson M, Wright A, Pirl W, Prigerson H (2010) Anxiety disorders in advanced cancer patients. Cancer 116:1810–1819
12. Greer JA, Pirl WF, Park ER, Lynch TJ, Temel JS (2008) Behavioral and psychological predictors of chemotherapy adherence in patients with advanced non-small cell lung cancer. J Psychosom Res 65:549–552
13. Prieto JM, Blanch J, Atala J, Carreras E, Rovira M, Cirera E, Gasto C (2002) Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation. J Clin Oncol 20:1907–1917
14. Swore Fletcher BA, Dodd MJ, Schumacher KL, Miaskowski C (2008) Symptom experience of family caregivers of patients with cancer. Oncol Nurs Forum 35:E23–E44
15. Spielberger CG, Gorsuch RL, Suchene R, Vagg PR, Jacobs GA (1983) Manual for the state-anxiety (form Y): self evaluation questionnaire. Consulting Psychologists Press, Palo Alto
16. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Müller CR, Hamer DH, Murphy DL (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527
17. Lau JY, Eley TC, Stevenson J (2006) Examining the state-trait anxiety relationship: a behavioural genetic approach. J Abnorm Child Psychol 34:19–27. doi:10.1007/s10802-005-9006-7
18. Stiegelis HE, Ranchor AV, Sanderman R (2004) Psychological functioning in cancer patients treated with radiotherapy. Patient Educ Couns 52:131–141
19. De Vries J, Van der Steeg AF, Roukema JA (2009) Trait anxiety determines depressive symptoms and fatigue in women with an abnormality in the breast. Br J Health Psychol 14:143–157. doi:10.1348/135910708X310200
20. D’Angelo C, Mirijello A, Leggio L, Ferrulli A, Carotenuto V, Icolaro N, Miceli A, D’Angelo V, Gasbarrini G, Addolorato G (2008) State and trait anxiety and depression in patients with primary brain tumors before and after surgery: 1-year longitudinal study. J Neurosurg 108:281–286
21. Ando N, Iwamitsu Y, Kuranami M, Okazaki S, Nakatani Y, Yamamoto K, Watanabe M, Miyaoka H (2011) Predictors of psychological distress after diagnosis in breast cancer patients and patients with benign breast problems. Psychosomatics 52:56–64
22. Aerts P, De Vries J, Van der Steeg A, Roukema J (2011) The relationship between morbidity after axillary surgery and long-term quality of life in breast cancer patients: The role of anxiety. Eur J Surg Oncol 37:344–349
23. Van Esch L, Roukema JA, Van der Steeg AFW, De Vries J (2011) Trait anxiety predicts disease-specific health status in early-stage breast cancer patients. Qual Life Res 20:865–873
24. Ristvedt SL, Trinkaus KM (2009) Trait anxiety as an independent predictor of poor health–related quality of life and post–traumatic stress symptoms in rectal cancer. Br J Health Psycho 14:701–715
25. Dunn LB, Aouizerat BE, Cooper BA, Dodd M, Lee K, West C, Paul SM, Wara W, Swift P, Miaskowski C (2012) Trajectories of anxiety in oncology patients and family caregivers during and after radiation therapy. Eur J Oncol Nurs 16:1–9. doi:10.1016/j.ejon.2011.01.003
26. Luciano M, Huffman JE, Arias-Vasquez A, Vinkhuyzen AA, Middeldorp CM, Giegling I, Payton A, Davies G, Zgaga L, Janzing J, Ke X, Galesloot T, Hartmann AM, Ollier W, Tenesa A, Hayward C, Verhagen M, Montgomery GW, Hottenga JJ, Konte B, Starr JM, Vitart V, Vos PE, Madden PA, Willemsen G, Konnerth H, Horan MA, Porteous DJ, Campbell H, Vermeulen SH, Heath AC, Wright A, Polasek O, Kovacevic SB, Hastie ND, Franke B, Boomsma DI, Martin NG, Rujescu D, Wilson JF, Buitelaar J, Pendleton N, Rudan I, Deary IJ (2012) Genome-wide association uncovers shared genetic effects among personality traits and mood states. Am J Med Genet B Neuropsychiatr Genet 159B:684–695. doi:10.1002/ajmg.b.32072
27. Webb BT, Guo AY, Maher BS, Zhao Z, van den Oord EJ, Kendler KS, Riley BP, Gillespie NA, Prescott CA, Middeldorp CM (2012) Meta-analyses of genome-wide linkage scans of anxiety-related phenotypes. Eur J Hum Genet 20:1078–1084
28. Domschke K, Deckert J (2012) Genetics of anxiety disorders—status quo and quo vadis. Curr Pharm Des 18:5691–5698
29. McGrath LM, Weill S, Robinson EB, Macrae R, Smoller JW (2012) Bringing a developmental perspective to anxiety genetics. Dev Psychopathol 24(4):1179–1193. doi:10.1017/S0954579412000636
30. Binder EB (2012) The genetic basis of mood and anxiety disorders—changing paradigms. Biol Mood Anxiety Disord 2:17. doi:10.1186/2045-5380-2-17
31. Sokolowska E, Hovatta I (2013) Anxiety genetics—findings from cross-species genome-wide approaches. Biol Mood Anxiety Disord 3:9. doi:10.1186/2045-5380-3-9
32. Hou R, Baldwin DS (2012) A neuroimmunological perspective on anxiety disorders. Hum Psychopharmacol 27:6–14. doi:10.1002/hup.1259
33. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK (2010) A metaanalysis of cytokines in major depression. Biol Psychiatry 67:446–457
34. Kustova Y, Sei Y, Morse HC Jr, Basile AS (1998) The influence of a targeted deletion of the IFN gamma gene on emotional behaviors. Brain Behav Immun 12:308–324
35. Lesch KP (2001) Mouse anxiety: the power of knockout. Pharmacogenomics J 1:187–192
36. Connor TJ, Leonard BE (1998) Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sci 62:583–606
37. Fiore M, Alleva E, Probert L, Kollias G, Angelucci F, Aloe L (1998) Exploratory and displacement behavior in transgenic mice expressing high levels of brain TNF-alpha. Physiol Behav 63:571–576
38. Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A, Pollmacher T (2001) Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 58:445–452
39. Illi J, Miaskowski C, Cooper B, Levine JD, Dunn L, West C, Dodd M, Dhruva A, Paul SM, Baggott C, Cataldo J, Langford D, Schmidt B, Aouizerat BE (2012) Association between pro- and anti-inflammatory cytokine genes and a symptom cluster of pain, fatigue, sleep disturbance, and depression. Cytokine 58:437–447. doi:10.1016/j.cyto.2012.02.015
40. McCann B, Miaskowski C, Koetters T, Baggott C, West C, Levine JD, Elboim C, Abrams G, Hamolsky D, Dunn L, Rugo H, Dodd M, Paul SM, Neuhaus J, Cooper B, Schmidt B, Langford D, Cataldo J, Aouizerat BE (2012) Associations between pro- and anti-inflammatory cytokine genes and breast pain in women prior to breast cancer surgery. J Pain 13:425–437. doi:10.1016/j.jpain.2011.02.358
41. Dunn LB, Aouizerat BE, Langford DJ, Cooper BA, Dhruva A, Cataldo JK, Baggott CR, Merriman JD, Dodd M, West C, Paul SM, Miaskowski C (2013) Cytokine gene variation is associated with depressive symptom trajectories in oncology patients and family caregivers. Eur J Oncol Nurs 17:346–353. doi:10.1016/j.ejon.2012.10.004
42. Miaskowski C, Cooper BA, Dhruva A, Dunn LB, Langford DJ, Cataldo JK, Baggott CR, Merriman JD, Dodd M, Lee K (2012) Evidence of associations between cytokine genes and subjective reports of sleep disturbance in oncology patients and their family caregivers. PLoS ONE 7:e40560
43. Vogelzangs N, Beekman AT, de Jonge P, Penninx BW (2013) Anxiety disorders and inflammation in a large adult cohort. Transl Psychiatry 3:e249. doi:10.1038/tp.2013.27
44. Bieling PJ, Antony MM, Swinson RP (1998) The State-Trait Anxiety Inventory, Trait version: structure and content re-examined. Behav Res Ther 36:777–788
45. Kennedy BL, Schwab JJ, Morris RL, Beldia G (2001) Assessment of state and trait anxiety in subjects with anxiety and depressive disorders. Psychiatr Q 72:263–276
46. Radloff LS (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401
47. Sheehan TJ, Fifield J, Reisine S, Tennen H (1995) The measurement structure of the Center for Epidemiologic Studies Depression Scale. J Pers Assess 64:507–521
48. Seruga B, Zhang H, Bernstein LJ, Tannock IF (2008) Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer 8:887–899
49. Conde L, Vaquerizas JM, Dopazo H, Arbiza L, Reumers J, Rousseau F, Schymkowitz J, Dopazo J (2006) PupaSuite: finding functional single nucleotide polymorphisms for large-scale genotyping purposes. Nucleic Acids Res 34:W621–W625
50. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M (2002) The structure of haplotype blocks in the human genome. Science 296:2225–2229
51. Stephens M, Smith NJ, Donnelly P (2001) A new statistical method for haplotype reconstruction from population data. Am J Human Genet 68:978–989
52. Tian C, Kosoy R, Lee A, Ransom M, Belmont JW, Gregersen PK, Seldin MF (2008) Analysis of East Asia genetic substructure using genome-wide SNP arrays. PLoS ONE 3:e3862
53. Hoggart CJ, Parra EJ, Shriver MD, Bonilla C, Kittles RA, Clayton DG, McKeigue PM (2003) Control of confounding of genetic associations in stratified populations. Am J Human Genet 72:1492
54. Halder I, Shriver M, Thomas M, Fernandez JR, Frudakis T (2008) A panel of ancestry informative markers for estimating individual biogeographical ancestry and admixture from four continents: utility and applications. Human Mutat 29:648–658
55. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38:904–909
56. Rothman KJ (1990) No adjustments are needed for multiple comparisons. Epidemiology 1:43–46
57. Hattersley AT, McCarthy MI (2005) What makes a good genetic association study? Lancet 366:1315–1323
58. Legrand LN, McGue M, Iacono WG (1999) A twin study of state and trait anxiety in childhood and adolescence. J Child Psychol Psychiatry 40:953–958
59. Wolitzky-Taylor KB, Castriotta N, Lenze EJ, Stanley MA, Craske MG (2010) Anxiety disorders in older adults: a comprehensive review. Depress Anxiety 27:190–211. doi:10.1002/da.20653
60. Wallace LM, Priestman SG, Dunn JA, Priestman TJ (1993) The quality of life of early breast cancer patients treated by two different radiotherapy regimens. Clin Oncol 5:228–233
61. Andersen BL, Tewfik HH (1985) Psychological reactions to radiation therapy: reconsideration of the adaptive aspects of anxiety. J Pers Soc Psychol 48:1024–1032
62. Valdes-Stauber J, Vietz E, Kilian R (2013) The impact of clinical conditions and social factors on the psychological distress of cancer patients: an explorative study at a consultation and liaison service in a rural general hospital. BMC Psychiatry 13:226. doi:10.1186/1471-244X-13-226
63. Reilly CM, Bruner DW, Mitchell SA, Minasian LM, Basch E, Dueck AC, Cella D, Reeve BB (2013) A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment. Support Care Cancer. doi:10.1007/s00520-012-1688-0
64. Schreier AM, Williams SA (2004) Anxiety and quality of life of women who receive radiation or chemotherapy for breast cancer. Oncol Nurs Forum 31:127–130. doi:10.1188/04.ONF.127-130
65. Michael YL, Kawachi I, Berkman LF, Holmes MD, Colditz GA (2000) The persistent impact of breast carcinoma on functional health status: prospective evidence from the Nurses’ Health Study. Cancer 89:2176–2186. doi:10.1002/1097-0142(20001201)89:11<2176::AID-CNCR5>3.0.CO;2-6
66. Ganz PA, Guadagnoli E, Landrum MB, Lash TL, Rakowski W, Silliman RA (2003) Breast cancer in older women: quality of life and psychosocial adjustment in the 15 months after diagnosis. J Clin Oncol 21:4027–4033. doi:10.1200/JCO.2003.08.097
67. Zhou ES, Penedo FJ, Bustillo NE, Benedict C, Rasheed M, Lechner S, Soloway M, Kava BR, Schneiderman N, Antoni MH (2010) Longitudinal effects of social support and adaptive coping on the emotional well-being of survivors of localized prostate cancer. J Support Oncol 8:196–201
68. Mallinckrodt B, Armer JM, Heppner PP (2012) A threshold model of social support, adjustment, and distress after breast cancer treatment. J Couns Psychol 59:150–160. doi:10.1037/a0026549
69. Alfaro E, Dhruva A, Langford DJ, Koetters T, Merriman JD, West C, Dunn LB, Paul SM, Cooper B, Cataldo J, Hamolsky D, Elboim C, Kober K, Aouizerat BE, Miaskowski C (2014) Associations between cytokine gene variations and self-reported sleep disturbance in women following breast cancer surgery. Eur J Oncol Nurs 18:85–93. doi:10.1016/j.ejon.2013.08.004
70. Miller AH, Haroon E, Raison CL, Felger JC (2013) Cytokine targets in the brain: impact on neurotransmitters and neurocircuits. Depress Anxiety 30:297–306. doi:10.1002/da.22084
71. Courtier N, Gambling T, Enright S, Barrett-Lee P, Abraham J, Mason MD (2013) Psychological and immunological characteristics of fatigued women undergoing radiotherapy for early-stage breast cancer. Support Care Cancer 21:173–181. doi:10.1007/s00520-012-1508-6
72. Dantzer R (2012) Depression and inflammation: an intricate relationship. Biol Psychiatry 71:4–5. doi:10.1016/j.biopsych.2011.10.025
73. Raison CL, Miller AH (2011) Is depression an inflammatory disorder? Curr Psychiatry Rep 13:467–475. doi:10.1007/s11920-011-0232-0
74. Lyon D, Elmore L, Aboalela N, Merrill-Schools J, McCain N, Starkweather A, Elswick RK Jr, Jackson-Cook C (2014) Potential epigenetic mechanism(s) associated with the persistence of psychoneurological symptoms in women receiving chemotherapy for breast cancer: a hypothesis. Biol Res Nurs 16(2):160–174
75. Thomas KS, Motivala S, Olmstead R, Irwin MR (2011) Sleep depth and fatigue: role of cellular inflammatory activation. Brain Behav Immun 25:53–58
76. Elenkov IJ, Iezzoni DG, Daly A, Harris AG, Chrousos GP (2005) Cytokine dysregulation, inflammation and well-being. Neuroimmunomodulation 12:255–269
77. Bay-Richter C, Janelidze S, Hallberg L, Brundin L (2011) Changes in behaviour and cytokine expression upon a peripheral immune challenge. Behav Brain Res 222:193–199. doi:10.1016/j.bbr.2011.03.060
78. Harrison NA, Brydon L, Walker C, Gray MA, Steptoe A, Dolan RJ, Critchley HD (2009) Neural origins of human sickness in interoceptive responses to inflammation. Biol Psychiatry 66:415–422
79. Tizard I (2008) Sickness behavior, its mechanisms and significance. Anim Health Res Rev 9:87–99
80. Dantzer R, Kelley KW (2007) Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun 21:153–160
81. Colotta F, Re F, Muzio M, Bertini R, Polentarutti N, Sironi M, Giri JG, Dower SK, Sims JE, Mantovani A (1993) Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 261:472–475
82. Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9:46–56
83. Miller AH, Ancoli-Israel S, Bower JE, Capuron L, Irwin MR (2008) Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol 26:971–982
84. Miller AH, Maletic V, Raison CL (2009) Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 65:732–741. doi:10.1016/j.biopsych.2008.11.029
85. Henje Blom E, Lekander M, Ingvar M, Asberg M, Mobarrez F, Serlachius E (2012) Pro-inflammatory cytokines are elevated in adolescent females with emotional disorders not treated with SSRIs. J Affect Disord 136:716–723. doi:10.1016/j.jad.2011.10.002
86. Moreau M, Lestage J, Verrier D, Mormede C, Kelley KW, Dantzer R, Castanon N (2005) Bacille Calmette-Guerin inoculation induces chronic activation of peripheral and brain indoleamine 2,3-dioxygenase in mice. J Infect Dis 192:537–544
87. Zhu CB, Blakely RD, Hewlett WA (2006) The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters. Neuropsychopharmacology 31:2121–2131
88. Snyder SH (2011) Serotonin, cytokines, p11, and depression. Proc Natl Acad Sci U S A 108(22):8923–8924. doi:10.1073/pnas.1106103108
89. Pace TW, Hu F, Miller AH (2007) Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav Immun 21:9–19
90. Rossi S, Sacchetti L, Napolitano F, De Chiara V, Motta C, Studer V, Musella A, Barbieri F, Bari M, Bernardi G, Maccarrone M, Usiello A, Centonze D (2012) Interleukin-1beta causes anxiety by interacting with the endocannabinoid system. J Neurosci 32:13896–13905. doi:10.1523/JNEUROSCI.1515-12.2012
91. Oeckinghaus A, Hayden MS, Ghosh S (2011) Crosstalk in NF-kappaB signaling pathways. Nat Immunol 12:695–708. doi:10.1038/ni.2065
92. Aouizerat BE, Dodd M, Lee K, West C, Paul SM, Cooper BA, Wara W, Swift P, Dunn LB, Miaskowski C (2009) Preliminary evidence of a genetic association between tumor necrosis factor alpha and the severity of sleep disturbance and morning fatigue. Biol Res Nurs 11:27–41
93. Abraham LJ, Kroeger KM (1999) Impact of the −308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukoc Biol 66:562–566
94. Kroeger KM, Carville KS, Abraham LJ (1997) The −308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 34:391–399
95. Kroeger KM, Steer JH, Joyce DA, Abraham LJ (2000) Effects of stimulus and cell type on the expression of the −308 tumour necrosis factor promoter polymorphism. Cytokine 12:110–119. doi:10.1006/cyto.1999.0529
96. Camara ML, Corrigan F, Jaehne EJ, Jawahar MC, Anscomb H, Koerner H, Baune BT (2013) TNF-alpha and its receptors modulate complex behaviours and neurotrophins in transgenic mice. Psychoneuroendocrinology 38:3102–3114. doi:10.1016/j.psyneuen.2013.09.010
97. Naude PJ, Dobos N, van der Meer D, Mulder C, Pawironadi KG, den Boer JA, van der Zee EA, Luiten PG, Eisel UL (2014) Analysis of cognition, motor performance and anxiety in young and aged tumor necrosis factor alpha receptor 1 and 2 deficient mice. Behav Brain Res 258:43–51. doi:10.1016/j.bbr.2013.10.006